- cafead Mar 04, 2025 at 12:12: AM
via Callio Therapeutics is debuting with an ADC technology and related programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.
article source
article source
Biotech startup pulls in $187M to make ‘multi-payload’ ADCs
- Thread starter cafead
- Start date